ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 113 filers reported holding ASSERTIO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $28,000 | -63.2% | 21,878 | -0.8% | 0.00% | -100.0% |
Q2 2019 | $76,000 | -31.5% | 22,058 | +0.5% | 0.00% | -50.0% |
Q1 2019 | $111,000 | +40.5% | 21,944 | +0.1% | 0.00% | 0.0% |
Q4 2018 | $79,000 | -12.2% | 21,925 | +43.7% | 0.00% | +100.0% |
Q3 2018 | $90,000 | – | 15,259 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Senvest Management, LLC | 5,006,637 | $29,439,000 | 2.23% |
ARMISTICE CAPITAL, LLC | 3,000,000 | $17,640,000 | 1.06% |
DELTEC ASSET MANAGEMENT LLC | 517,606 | $3,044,000 | 0.58% |
PERKINS CAPITAL MANAGEMENT INC | 125,550 | $738,000 | 0.44% |
Matarin Capital Management, LLC | 600,223 | $3,529,311,000 | 0.23% |
GLOBEFLEX CAPITAL L P | 196,615 | $1,156,000 | 0.23% |
ALGERT GLOBAL LLC | 139,129 | $818,000 | 0.18% |
TSP Capital Management Group, LLC | 53,575 | $315,000 | 0.16% |
CORNERCAP INVESTMENT COUNSEL INC | 157,235 | $925,000 | 0.12% |
Connor, Clark & Lunn Investment Management Ltd. | 3,060,189 | $17,994,000 | 0.10% |